Table 1.

Evaluable patient characteristics

UPN	Age (Years)	Race/Sex	Surgery	Chemotherapy/Radiation	Time to Progression
1	60	W/F	Partial resection	TMZ + ABT-510/XRT	6 months
2	47	W/F	Gross total resection	TMZ/XRT	11 months
3	77	W/F	Partial resection	None	0 months
4	53	W/F	Partial resection	TMZ/XRT	13 months
5	40	W/F	Partial resection	TMZ/XRT	10 months NEDa
6	67	W/F	Gross total resection	TMZ + ABT-510/XRT	8 months out with NED
7	58	W/M	Gross total resection	None	Hospice post-op
8	67	W/M	Partial resection	TMZ/XRT	5 months
9	64	AA/F	Partial resection	TMZ/XRT	7 months out with SD
10	79	W/F	Partial resection; GW	Lost to F/U	Lost to F/U
11	61	W/M	Resection at OSH; GW	TMZ/XRT	15 months
12	50	W/M	Resection at OSH	TMZ/XRT	11 months
13	71	W/F	Partial resection	TMZ + ABT-510/XRT	9 months
14	74	W/F	Resection at OSH	TMZ/XRT	Stage IV lung cancer→hospice
15	53	W/F	Partial resection	Lost to F/U	Lost to F/U

Abbreviations: UPN, unique patient number; W, white; F, female; TMZ, temozolomide; XRT, radiation therapy; NED, no evidence of disease; M, male; AA, African American; SD, stable disease; GW, Gliadel wafers; F/U, follow-up; OSH, outside hospital.

^aBut with radiation necrosis.